Alfonso M. Lostia

Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009

Niklas Andersson, Maria Arena, Domenica Auteri et al. · EFSA Journal · 2018 · 535 citations · Full text

Pharmacy, Toxicology, Environmental Toxicology +16

HPLC–mass spectrometry method for quantitative detection of neuroendocrine tumor markers: Vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid

Luana Lionetto, Alfonso M. Lostia, Antonio Stigliano et al. · Clinica Chimica Acta · 2008 · 79 citations

Medicine, Endocrinology, Oncology +11

A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability

Alfonso M. Lostia, Luana Lionetto, Luigi Principessa et al. · Clinical Biochemistry · 2008 · 53 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +14

Serum Levels of Risperidone and Its Metabolite, 9-Hydroxyrisperidone: Correlation Between Drug Concentration and Clinical Response

Alfonso M. Lostia, Lorenzo Mazzarini, Isabella Pacchiarotti et al. · Therapeutic Drug Monitoring · 2009 · 43 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Measurement of Ethyl Glucuronide, Ethyl Sulphate and Their Ratio in the Urine and Serum of Healthy Volunteers after Two Doses of Alcohol

Alfonso M. Lostia, J. L. Vicente · Alcohol and Alcoholism · 2012 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16